In this study, through an in-depth study of the structure and function of filaggrin, a new treatment option for atopic dermatitis was proposed, i.e., the use of recombinant human filaggrin (rhFLA-10), which contains a functional fragment of filaggrin. This evidence concerns the gene FLG and atopic eczema.